XENE compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

XENEXenon Pharmaceuticals Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

XENEXenon Pharmaceuticals Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

XENEXenon Pharmaceuticals Inc.

38.32▲+1.86%· post 38.49

Mkt cap$3.6BRevenue$8MQ1 FY25Revenue—

LLYELI Lilly & Co

1,407.25▼−0.27%· post 1,416.42

ClosedNov 3 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 3 '26

XENEXenon Pharmaceuticals Inc.

LLYELI Lilly & Co

38.32▲+1.86%post 38.49

Price

1,407.25▼−0.27%post 1,416.42

$3.6B

Mkt cap

$1.3T

Q1 FY25$8M

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

XENE38.32▲+1.86%vsLLY1,407.25▼−0.27%ClosedNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

XENE: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only XENE 2

NBIXNeurocrine Biosciencessupplier

BHCBausch Healthsupplier

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customerSource: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

XENE, solidLLY, dashed